Cargando…
Predictive Value of [(99m)Tc]-MAA-Based Dosimetry in Hepatocellular Carcinoma Patients Treated with [(90)Y]-TARE: A Single-Center Experience
Transarterial radioembolization is a well-established method for the treatment of hepatocellular carcinoma. The tolerability and incidence of hepatic decompensation are related to the doses delivered to the tumor and healthy liver. This retrospective study was performed at our center to evaluate whe...
Autores principales: | Doppler, Michael, Reincke, Marlene, Bettinger, Dominik, Vogt, Katharina, Weiss, Jakob, Schultheiss, Michael, Uller, Wibke, Verloh, Niklas, Goetz, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378141/ https://www.ncbi.nlm.nih.gov/pubmed/37510175 http://dx.doi.org/10.3390/diagnostics13142432 |
Ejemplares similares
-
Hepatic decompensation after transarterial radioembolization: A retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma
por: Reincke, Marlene, et al.
Publicado: (2022) -
Factors modulating (99m)Tc‐MAA planar lung dosimetry for (90)Y radioembolization
por: Lopez, Benjamin P., et al.
Publicado: (2022) -
Erratum: “Factors modulating (99m)Tc‐MAA planar lung dosimetry for (90)Y radioembolization”
Publicado: (2023) -
Predictive value of (99m)Tc-MAA-based dosimetry in personalized (90)Y-SIRT planning for liver malignancies
por: Riveira-Martin, Mercedes, et al.
Publicado: (2023) -
Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres
por: Garin, Etienne, et al.
Publicado: (2015)